Nature Communications (Jan 2021)

An autophagy enhancer ameliorates diabetes of human IAPP-transgenic mice through clearance of amyloidogenic oligomer

  • Jinyoung Kim,
  • Kihyoun Park,
  • Min Jung Kim,
  • Hyejin Lim,
  • Kook Hwan Kim,
  • Sun-Woo Kim,
  • Eun-Seo Lee,
  • Hyongbum (Henry) Kim,
  • Sung Joo Kim,
  • Kyu Yeon Hur,
  • Jae Hyeon Kim,
  • Jin Hee Ahn,
  • Kun-Ho Yoon,
  • Ji-Won Kim,
  • Myung-Shik Lee

DOI
https://doi.org/10.1038/s41467-020-20454-z
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 15

Abstract

Read online

Islet amyloid polypeptide (IAPP) deposition is associated with islet cell loss in diabetes. Here the authors show that a small molecule autophagy enhancer reduces IAPP accumulation in vitro, and also improves glucose tolerance in hIAPP + mice fed high-fat diet, accompanied by reduced hIAPP accumulation, in vivo.